Skip to main content
Genfit S.A. logo

Genfit S.A. — Investor Relations & Filings

Ticker · GNFT US Manufacturing
Open in API
Filings indexed 210 across all filing types
Latest filing 2025-11-20 Regulatory Filings
Country US United States of America
Listing US GNFT

About Genfit S.A.

https://www.genfit.fr/

Genfit S.A. is a late-stage biopharmaceutical company dedicated to discovering and developing therapeutic solutions for severe and life-threatening liver diseases with high unmet medical needs. The company's pipeline focuses on drug candidates with complementary mechanisms of action that target key pathophysiological pathways in conditions such as Acute-on-Chronic Liver Failure (ACLF). A key asset, developed in partnership with Ipsen, received accelerated approval from the U.S. FDA for a chronic liver disease. This therapy works by activating specific receptors to reduce inflammation and manage bile acids. Genfit also develops diagnostic solutions and strategically expands its portfolio through acquisitions and licensing agreements to advance its research in liver disease.

Recent filings

Filing Released Lang Actions
15F-12B
Regulatory Filings Classification · 100% confidence The document is a Form 15F filed with the SEC, which is a certification of a foreign private issuer's termination of registration of a class of securities or termination of the duty to file reports under the Securities Exchange Act of 1934. It references the company's delisting from Nasdaq and termination of reporting obligations. The document is regulatory in nature, certifying compliance with SEC rules for deregistration and termination of reporting duties. It does not contain financial statements, earnings data, or management discussion, but rather is a formal regulatory filing certifying a change in reporting status. Therefore, it fits best under Regulatory Filings (RNS).
2025-11-20 English
S-8 POS
Capital/Financing Update Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to a Form S-8 Registration Statement filed with the SEC. Form S-8 is used for registering securities to be offered under employee benefit plans. The document discusses removing unsold securities from registration as per the undertakings in the original registration statement. It is a regulatory filing related to securities registration and deregistration, not a financial report, earnings release, or management discussion. The document is about capital structure changes related to share plans but is specifically a post-effective amendment to a registration statement, which fits best under the category of Capital/Financing Update (CAP). The document length is 5796 characters, which is sufficient to be the actual filing, not just an announcement. Therefore, the classification is CAP with high confidence.
2025-11-14 English
Regulatory Filings 2025
Regulatory Filings Classification · 100% confidence The document is a formal letter from GENFIT S.A. to the U.S. Securities and Exchange Commission requesting the withdrawal of a previously filed registration statement on Form F-3. It references regulatory rules under the Securities Act and discusses the withdrawal of a registration statement that was declared effective but under which no securities were issued or sold. The document is a regulatory communication related to capital markets filings but does not contain financial data, earnings, or report content. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to capital markets compliance and procedural matters. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short and it is a formal request letter, not a report or announcement of a report publication.
2025-11-14 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1151 characters), and it primarily serves as a regulatory filing to report information to the SEC. There is no indication that this is an annual report, earnings release, or other specific financial report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2025-11-10 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data itself. The document length is short (1152 characters), and it primarily serves as a regulatory filing to report information to the SEC. There is no indication that this is a full annual report, earnings release, or other detailed financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2025-11-10 English
25
Delisting Announcement
2025-11-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.